146 related articles for article (PubMed ID: 3266957)
1. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
Kopin IJ; Bankiewicz KS; Harvey-White J
Neuropsychopharmacology; 1988 May; 1(2):119-25. PubMed ID: 3266957
[TBL] [Abstract][Full Text] [Related]
2. Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
Kopin IJ; Bankiewicz K; Harvey-White J
Life Sci; 1988; 43(2):133-41. PubMed ID: 3260652
[TBL] [Abstract][Full Text] [Related]
3. A new approach to biochemical evaluation of brain dopamine metabolism.
Kopin IJ; White JH; Bankiewicz K
Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
[TBL] [Abstract][Full Text] [Related]
4. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
Sternberg DE; Heninger GR; Roth RH
Life Sci; 1983 May; 32(21):2447-52. PubMed ID: 6855448
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
Amin F; Davidson M; Kahn RS; Schmeidler J; Stern R; Knott PJ; Apter S
Schizophr Bull; 1995; 21(1):53-66. PubMed ID: 7770741
[TBL] [Abstract][Full Text] [Related]
6. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
Riddle MA; Leckman JF; Cohen DJ; Anderson M; Ort SI; Caruso KA; Shaywitz BA
J Neural Transm; 1986; 67(1-2):31-43. PubMed ID: 3465864
[TBL] [Abstract][Full Text] [Related]
7. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Maas JW; Contreras SA; Seleshi E; Bowden CL
Arch Gen Psychiatry; 1988 Jun; 45(6):553-9. PubMed ID: 3377641
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
Greene KA; Faull KF
J Neurochem; 1989 Oct; 53(4):1007-13. PubMed ID: 2769251
[TBL] [Abstract][Full Text] [Related]
9. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J
Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone increases plasma HVA but not MHPG in normal humans.
Wolkowitz OM; Sutton ME; Doran AR; Labarca R; Roy A; Thomas JW; Pickar D; Paul SM
Psychiatry Res; 1985 Oct; 16(2):101-9. PubMed ID: 3865250
[TBL] [Abstract][Full Text] [Related]
12. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging.
Amin F; Seeman TE; Mohs RC; Davidson M; Knott P; Berkman LF; Albert M; Blazer D
Neuropsychopharmacology; 1994 Feb; 10(1):29-35. PubMed ID: 8179792
[TBL] [Abstract][Full Text] [Related]
13. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
[TBL] [Abstract][Full Text] [Related]
14. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
Kendler KS; Heninger GR; Roth RH
Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
[TBL] [Abstract][Full Text] [Related]
15. Effects of debrisoquin on CSF and plasma HVA concentrations in man.
Maas JW; Contreras SA; Bowden CL; Weintraub SE
Life Sci; 1985 Jun; 36(22):2163-70. PubMed ID: 3999921
[TBL] [Abstract][Full Text] [Related]
16. Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin.
Swann AC; Maas JW; Hattox SE; Landis H
Life Sci; 1980 Nov; 27(20):1857-62. PubMed ID: 7193269
[No Abstract] [Full Text] [Related]
17. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
Hovevey-Sion D; Kopin IJ; Stull RW; Goldstein DS
Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
[TBL] [Abstract][Full Text] [Related]
18. Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys.
Rogeness GA; Javors MA; Maas JW; Macedo CA; Fischer C
Biol Psychiatry; 1987 Sep; 22(9):1158-62. PubMed ID: 3651534
[No Abstract] [Full Text] [Related]
19. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Di Paolo T; Bédard P; Daigle M; Boucher R
Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166
[TBL] [Abstract][Full Text] [Related]
20. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.
Markianos E; Backman H
J Neural Transm; 1976; 39(1-2):79-93. PubMed ID: 988114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
